These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25591905)

  • 1. Sensory modulation and daily-life participation in people with schizophrenia.
    Lipskaya-Velikovsky L; Bar-Shalita T; Bart O
    Compr Psychiatry; 2015 Apr; 58():130-7. PubMed ID: 25591905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation in daily life of people with schizophrenia in comparison to the general population.
    Lipskaya-Velikovsky L; Jarus T; Easterbrook A; Kotler M
    Can J Occup Ther; 2016 Dec; 83(5):297-305. PubMed ID: 27246199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the intensity and diversity of day-to-day activities among people with schizophrenia using parameters obtained during acute hospitalization.
    Lipskaya-Velikovsky L; Jarus T; Kotler M
    Disabil Rehabil; 2017 Jun; 39(13):1300-1306. PubMed ID: 27346369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive screening and behavioural observation of functional ability in patients with multiple episode schizophrenia: an exploratory study.
    Norlin Bagge E; Esbjörnsson E; Sunnerhagen KS
    BMJ Open; 2017 Jun; 7(6):e014783. PubMed ID: 28645961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial support and cognitive deficits in adults with schizophrenia.
    Dalagdi A; Arvaniti A; Papatriantafyllou J; Xenitidis K; Samakouri M; Livaditis M
    Int J Soc Psychiatry; 2014 Aug; 60(5):417-25. PubMed ID: 23828764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discrimination perceived by people with a diagnosis of schizophrenic disorders. INternational study of DIscrimination and stiGma Outcomes (INDIGO): French results].
    Daumerie N; Vasseur Bacle S; Giordana JY; Bourdais Mannone C; Caria A; Roelandt JL
    Encephale; 2012 Jun; 38(3):224-31. PubMed ID: 22726410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From hospital admission to independent living: is prediction possible?
    Lipskaya-Velikovsky L; Kotler M; Easterbrook A; Jarus T
    Psychiatry Res; 2015 Apr; 226(2-3):499-506. PubMed ID: 25747682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the understanding of the link between cognition and functional capacity in schizophrenia and bipolar disorder.
    Moore RC; Harmell AL; Harvey PD; Bowie CR; Depp CA; Pulver AE; McGrath JA; Patterson TL; Cardenas V; Wolyniec P; Thornquist MH; Luke JR; Palmer BW; Jeste DV; Mausbach BT
    Schizophr Res; 2015 Dec; 169(1-3):121-127. PubMed ID: 26427917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation restrictions in patients with psychiatric and/or cognitive disabilities: preliminary results for an ICF-derived assessment tool.
    Belio C; Prouteau A; Koleck M; Saada Y; Merceron K; Dayre E; Destaillats JM; Barral C; Mazaux JM
    Ann Phys Rehabil Med; 2014 Mar; 57(2):114-37. PubMed ID: 24364986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity.
    Strassnig MT; Raykov T; O'Gorman C; Bowie CR; Sabbag S; Durand D; Patterson TL; Pinkham A; Penn DL; Harvey PD
    Schizophr Res; 2015 Jun; 165(1):76-82. PubMed ID: 25868935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL
    Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
    Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
    J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental Adaptations Improve Everyday Action in Schizophrenia.
    Kessler RK; Rhodes E; Giovannetti T
    J Int Neuropsychol Soc; 2015 May; 21(5):319-29. PubMed ID: 26028053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective well-being, but not subjective mental functioning shows positive associations with neuropsychological performance in schizophrenia-spectrum disorders.
    Schroeder K; Huber CG; Jelinek L; Moritz S
    Compr Psychiatry; 2013 Oct; 54(7):824-30. PubMed ID: 23602393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationships between schizophrenia symptom dimensions and executive functioning components.
    Clark LK; Warman D; Lysaker PH
    Schizophr Res; 2010 Dec; 124(1-3):169-75. PubMed ID: 20800998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life satisfaction and happiness among young adults with schizophrenia.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Psychiatry Res; 2016 Aug; 242():174-179. PubMed ID: 27288735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupation-focused intervention for in-patient mental health settings: Pilot study of effectiveness.
    Lipskaya-Velikovsky L; Krupa T; Silvan-Kosovich I; Kotler M
    J Psychiatr Res; 2020 Jun; 125():45-51. PubMed ID: 32203739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.